INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer

BACKGROUND: Previous research suggests the therapeutic cancer vaccine L-BLP25 potentially provides a survival benefit in patients with locally advanced unresectable stage III non-small cell lung carcinoma (NSCLC). These promising findings prompted the phase III study, INSPIRE, in patients of East-As...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wu, Yi-Long, Park, Keunchil, Soo, Ross A, Sun, Yan, Tyroller, Karin, Wages, David, Ely, Guy, Yang, James Chih-Hsin, Mok, Tony
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2011
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3203100/
https://ncbi.nlm.nih.gov/pubmed/21982342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-430
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars